世界の胃がん治療薬市場2017

QYResearchが発行した調査報告書(QYR70302116)
◆英語タイトル:Global Gastric Cancer Drug Sales Market Report 2017
◆商品コード:QYR70302116
◆発行会社(リサーチ会社):QYResearch
◆発行日:2017年2月13日
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥896,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界の胃がん治療薬市場2017について調査・分析し、胃がん治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、主要地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、コスト分析、価格データ、企業情報、胃がん治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・胃がん治療薬市場概要
・胃がん治療薬のメーカー別販売量・メーカー別シェア
・胃がん治療薬の世界市場:種類別販売量・市場シェア
・胃がん治療薬の世界市場:用途別販売量・市場シェア
・胃がん治療薬の世界市場:地域別販売量・市場シェア
・胃がん治療薬の米国市場規模
・胃がん治療薬の中国市場規模
・胃がん治療薬の欧州市場規模
・胃がん治療薬の日本市場規模
・胃がん治療薬の東南アジア市場規模
・胃がん治療薬のインド市場規模
・胃がん治療薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・胃がん治療薬のコスト分析・価格動向
・胃がん治療薬の産業チェーン(サプライチェーン分析)
・胃がん治療薬のマーケティング戦略・販売チャネル、流通業者
・胃がん治療薬市場への影響要因分析
・胃がん治療薬の世界市場予測
・胃がん治療薬の米国市場予測
・胃がん治療薬の中国市場予測
・胃がん治療薬の欧州市場予測
・胃がん治療薬の日本市場予測
・胃がん治療薬の東南アジア市場予測
・胃がん治療薬のインド市場予測
・胃がん治療薬の種類別世界市場予測
・胃がん治療薬の用途別世界市場予測
...
【レポートの概要】

Notes:Sales, means the sales volume of Gastric Cancer Drug
Revenue, means the sales value of Gastric Cancer Drug

This report studies sales (consumption) of Gastric Cancer Drug in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Hoffmann-La Roche
Eli-lilly
Sanofi
Otsuka Holdings
Novartis
Amgen
Boston Biomedical
AROG Pharmaceuticals
ARIAD Pharmaceuticals
Roche
Merck
Eli Lilly
AB Science
Bayer HealthCare
Boehringer Ingelheim
Bristol-Myers Squibb
Five Prime
BIND Therapeutics
Ipsen Biopharmaceuticals
Eddingpharm

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Gastric Cancer Drug in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Gastric Cancer Drug in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

Global Gastric Cancer Drug Sales Market Report 2017
1 Gastric Cancer Drug Overview
1.1 Product Overview and Scope of Gastric Cancer Drug
1.2 Classification of Gastric Cancer Drug
1.2.1 Type I
1.2.2 Type II
1.3 Application of Gastric Cancer Drug
1.3.1 Application 1
1.3.2 Application 2
1.4 Gastric Cancer Drug Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Gastric Cancer Drug (2012-2022)
1.5.1 Global Gastric Cancer Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Gastric Cancer Drug Revenue and Growth Rate (2012-2022)

2 Global Gastric Cancer Drug Competition by Manufacturers, Type and Application
2.1 Global Gastric Cancer Drug Market Competition by Manufacturers
2.1.1 Global Gastric Cancer Drug Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Gastric Cancer Drug Revenue and Share by Manufacturers (2012-2017)
2.2 Global Gastric Cancer Drug (Volume and Value) by Type
2.2.1 Global Gastric Cancer Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Gastric Cancer Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Gastric Cancer Drug (Volume and Value) by Regions
2.3.1 Global Gastric Cancer Drug Sales and Market Share by Regions (2012-2017)
2.3.2 Global Gastric Cancer Drug Revenue and Market Share by Regions (2012-2017)
2.4 Global Gastric Cancer Drug (Volume) by Application

3 United States Gastric Cancer Drug (Volume, Value and Sales Price)
3.1 United States Gastric Cancer Drug Sales and Value (2012-2017)
3.1.1 United States Gastric Cancer Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Gastric Cancer Drug Sales Price Trend (2012-2017)
3.2 United States Gastric Cancer Drug Sales and Market Share by Manufacturers
3.3 United States Gastric Cancer Drug Sales and Market Share by Type
3.4 United States Gastric Cancer Drug Sales and Market Share by Application

4 China Gastric Cancer Drug (Volume, Value and Sales Price)
4.1 China Gastric Cancer Drug Sales and Value (2012-2017)
4.1.1 China Gastric Cancer Drug Sales and Growth Rate (2012-2017)
4.1.2 China Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Gastric Cancer Drug Sales Price Trend (2012-2017)
4.2 China Gastric Cancer Drug Sales and Market Share by Manufacturers
4.3 China Gastric Cancer Drug Sales and Market Share by Type
4.4 China Gastric Cancer Drug Sales and Market Share by Application

5 Europe Gastric Cancer Drug (Volume, Value and Sales Price)
5.1 Europe Gastric Cancer Drug Sales and Value (2012-2017)
5.1.1 Europe Gastric Cancer Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Gastric Cancer Drug Sales Price Trend (2012-2017)
5.2 Europe Gastric Cancer Drug Sales and Market Share by Manufacturers
5.3 Europe Gastric Cancer Drug Sales and Market Share by Type
5.4 Europe Gastric Cancer Drug Sales and Market Share by Application

6 Japan Gastric Cancer Drug (Volume, Value and Sales Price)
6.1 Japan Gastric Cancer Drug Sales and Value (2012-2017)
6.1.1 Japan Gastric Cancer Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Gastric Cancer Drug Sales Price Trend (2012-2017)
6.2 Japan Gastric Cancer Drug Sales and Market Share by Manufacturers
6.3 Japan Gastric Cancer Drug Sales and Market Share by Type
6.4 Japan Gastric Cancer Drug Sales and Market Share by Application
7 Southeast Asia Gastric Cancer Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Gastric Cancer Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Gastric Cancer Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Gastric Cancer Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Gastric Cancer Drug Sales and Market Share by Manufacturers
7.3 Southeast Asia Gastric Cancer Drug Sales and Market Share by Type
7.4 Southeast Asia Gastric Cancer Drug Sales and Market Share by Application
8 India Gastric Cancer Drug (Volume, Value and Sales Price)
8.1 India Gastric Cancer Drug Sales and Value (2012-2017)
8.1.1 India Gastric Cancer Drug Sales and Growth Rate (2012-2017)
8.1.2 India Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Gastric Cancer Drug Sales Price Trend (2012-2017)
8.2 India Gastric Cancer Drug Sales and Market Share by Manufacturers
8.3 India Gastric Cancer Drug Sales and Market Share by Type
8.4 India Gastric Cancer Drug Sales and Market Share by Application

9 Global Gastric Cancer Drug Manufacturers Analysis
9.1 Hoffmann-La Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Gastric Cancer Drug Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Hoffmann-La Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Eli-lilly
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Gastric Cancer Drug Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli-lilly Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Sanofi
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Gastric Cancer Drug Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Otsuka Holdings
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Gastric Cancer Drug Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Otsuka Holdings Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Novartis
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Gastric Cancer Drug Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Novartis Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Amgen
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Gastric Cancer Drug Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Amgen Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Boston Biomedical
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Gastric Cancer Drug Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Boston Biomedical Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 AROG Pharmaceuticals
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Gastric Cancer Drug Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 AROG Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 ARIAD Pharmaceuticals
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Gastric Cancer Drug Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 ARIAD Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Roche
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Gastric Cancer Drug Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Merck
9.12 Eli Lilly
9.13 AB Science
9.14 Bayer HealthCare
9.15 Boehringer Ingelheim
9.16 Bristol-Myers Squibb
9.17 Five Prime
9.18 BIND Therapeutics
9.19 Ipsen Biopharmaceuticals
9.20 Eddingpharm

10 Gastric Cancer Drug Maufacturing Cost Analysis
10.1 Gastric Cancer Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Gastric Cancer Drug
10.3 Manufacturing Process Analysis of Gastric Cancer Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Gastric Cancer Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Gastric Cancer Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Gastric Cancer Drug Market Forecast (2017-2022)
14.1 Global Gastric Cancer Drug Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Gastric Cancer Drug Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Gastric Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Gastric Cancer Drug Price and Trend Forecast (2017-2022)
14.2 Global Gastric Cancer Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Gastric Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Gastric Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Gastric Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Gastric Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Gastric Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Gastric Cancer Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Gastric Cancer Drug Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Gastric Cancer Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Gastric Cancer Drug
Table Classification of Gastric Cancer Drug
Figure Global Sales Market Share of Gastric Cancer Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Gastric Cancer Drug
Figure Global Sales Market Share of Gastric Cancer Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure China Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure Europe Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure Japan Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure India Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Figure Global Gastric Cancer Drug Sales and Growth Rate (2012-2022)
Figure Global Gastric Cancer Drug Revenue and Growth Rate (2012-2022)
Table Global Gastric Cancer Drug Sales of Key Manufacturers (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Gastric Cancer Drug Sales Share by Manufacturers
Figure 2016 Gastric Cancer Drug Sales Share by Manufacturers
Table Global Gastric Cancer Drug Revenue by Manufacturers (2012-2017)
Table Global Gastric Cancer Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Gastric Cancer Drug Revenue Share by Manufacturers
Table 2016 Global Gastric Cancer Drug Revenue Share by Manufacturers
Table Global Gastric Cancer Drug Sales and Market Share by Type (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Gastric Cancer Drug by Type (2012-2017)
Figure Global Gastric Cancer Drug Sales Growth Rate by Type (2012-2017)
Table Global Gastric Cancer Drug Revenue and Market Share by Type (2012-2017)
Table Global Gastric Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastric Cancer Drug by Type (2012-2017)
Figure Global Gastric Cancer Drug Revenue Growth Rate by Type (2012-2017)
Table Global Gastric Cancer Drug Sales and Market Share by Regions (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Gastric Cancer Drug by Regions (2012-2017)
Figure Global Gastric Cancer Drug Sales Growth Rate by Regions (2012-2017)
Table Global Gastric Cancer Drug Revenue and Market Share by Regions (2012-2017)
Table Global Gastric Cancer Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Gastric Cancer Drug by Regions (2012-2017)
Figure Global Gastric Cancer Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Gastric Cancer Drug Sales and Market Share by Application (2012-2017)
Table Global Gastric Cancer Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Gastric Cancer Drug by Application (2012-2017)
Figure Global Gastric Cancer Drug Sales Growth Rate by Application (2012-2017)
Figure United States Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure United States Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure United States Gastric Cancer Drug Sales Price Trend (2012-2017)
Table United States Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table United States Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table United States Gastric Cancer Drug Sales by Type (2012-2017)
Table United States Gastric Cancer Drug Market Share by Type (2012-2017)
Table United States Gastric Cancer Drug Sales by Application (2012-2017)
Table United States Gastric Cancer Drug Market Share by Application (2012-2017)
Figure China Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure China Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure China Gastric Cancer Drug Sales Price Trend (2012-2017)
Table China Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table China Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table China Gastric Cancer Drug Sales by Type (2012-2017)
Table China Gastric Cancer Drug Market Share by Type (2012-2017)
Table China Gastric Cancer Drug Sales by Application (2012-2017)
Table China Gastric Cancer Drug Market Share by Application (2012-2017)
Figure Europe Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure Europe Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Europe Gastric Cancer Drug Sales Price Trend (2012-2017)
Table Europe Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table Europe Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table Europe Gastric Cancer Drug Sales by Type (2012-2017)
Table Europe Gastric Cancer Drug Market Share by Type (2012-2017)
Table Europe Gastric Cancer Drug Sales by Application (2012-2017)
Table Europe Gastric Cancer Drug Market Share by Application (2012-2017)
Figure Japan Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure Japan Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Japan Gastric Cancer Drug Sales Price Trend (2012-2017)
Table Japan Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table Japan Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table Japan Gastric Cancer Drug Sales by Type (2012-2017)
Table Japan Gastric Cancer Drug Market Share by Type (2012-2017)
Table Japan Gastric Cancer Drug Sales by Application (2012-2017)
Table Japan Gastric Cancer Drug Market Share by Application (2012-2017)
Figure Southeast Asia Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure Southeast Asia Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Gastric Cancer Drug Sales Price Trend (2012-2017)
Table Southeast Asia Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table Southeast Asia Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table Southeast Asia Gastric Cancer Drug Sales by Type (2012-2017)
Table Southeast Asia Gastric Cancer Drug Market Share by Type (2012-2017)
Table Southeast Asia Gastric Cancer Drug Sales by Application (2012-2017)
Table Southeast Asia Gastric Cancer Drug Market Share by Application (2012-2017)
Figure India Gastric Cancer Drug Sales and Growth Rate (2012-2017)
Figure India Gastric Cancer Drug Revenue and Growth Rate (2012-2017)
Figure India Gastric Cancer Drug Sales Price Trend (2012-2017)
Table India Gastric Cancer Drug Sales by Manufacturers (2012-2017)
Table India Gastric Cancer Drug Market Share by Manufacturers (2012-2017)
Table India Gastric Cancer Drug Sales by Type (2012-2017)
Table India Gastric Cancer Drug Market Share by Type (2012-2017)
Table India Gastric Cancer Drug Sales by Application (2012-2017)
Table India Gastric Cancer Drug Market Share by Application (2012-2017)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Gastric Cancer Drug Global Market Share (2012-2017)
Table Eli-lilly Basic Information List
Table Eli-lilly Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli-lilly Gastric Cancer Drug Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Gastric Cancer Drug Global Market Share (2012-2017)
Table Otsuka Holdings Basic Information List
Table Otsuka Holdings Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Otsuka Holdings Gastric Cancer Drug Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Gastric Cancer Drug Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Gastric Cancer Drug Global Market Share (2012-2017)
Table Boston Biomedical Basic Information List
Table Boston Biomedical Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boston Biomedical Gastric Cancer Drug Global Market Share (2012-2017)
Table AROG Pharmaceuticals Basic Information List
Table AROG Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AROG Pharmaceuticals Gastric Cancer Drug Global Market Share (2012-2017)
Table ARIAD Pharmaceuticals Basic Information List
Table ARIAD Pharmaceuticals Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure ARIAD Pharmaceuticals Gastric Cancer Drug Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Gastric Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Gastric Cancer Drug Global Market Share (2012-2017)
Table Merck Basic Information List
Table Eli Lilly Basic Information List
Table AB Science Basic Information List
Table Bayer HealthCare Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Bristol-Myers Squibb Basic Information List
Table Five Prime Basic Information List
Table BIND Therapeutics Basic Information List
Table Ipsen Biopharmaceuticals Basic Information List
Table Eddingpharm Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastric Cancer Drug
Figure Manufacturing Process Analysis of Gastric Cancer Drug
Figure Gastric Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastric Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Gastric Cancer Drug
Table Distributors/Traders List
Figure Global Gastric Cancer Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Gastric Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Gastric Cancer Drug Sales Forecast by Regions (2017-2022)
Table Global Gastric Cancer Drug Sales Forecast by Type (2017-2022)
Table Global Gastric Cancer Drug Sales Forecast by Application (2017-2022)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の胃がん治療薬市場2017(Global Gastric Cancer Drug Sales Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆